1999, Number 2
<< Back Next >>
Rev Mex Cardiol 1999; 10 (2)
Sildenafil in men with coronary heart disease: Clinical and epidemiological implications
Canale JM, Bustamante F
Language: Spanish
References: 20
Page: 85-89
PDF size: 77.00 Kb.
ABSTRACT
The prevalence of coronary heart disease in adult and elderly men in Mexico is remarkable as it is the prevalence of erectile dysfunction. The use of sildenafil in the management of the erectile dysfunction is becoming more popular and involves today a great number of middle and advanced-age men. The simultaneous occurrence of ischemic heart disease with the procurement for the use of sildenafil implies peculiar characteristics and potential risks that are relevant since the clinical and epidemiological scopes. We here describe a concise analysis of the clinical and epidemiological implications of sildenafil use in men with coronary disease as we consider them to be relevant for the practitioner.
REFERENCES
Centro de información y Documentación Empresarial sobre Iberoamérica (CIDEIBER), 1998.
INEGI: XI Censo Nacional de Población y Vivienda, 1990, y Conteo de Población y Vivienda, 1995.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
Zusman RM. Cardiovascular data on sildenafil citrate: Introduction. Am J Cardiol 1999; 83: 1C-2C.
Summary of Death Reports in Viagra Received from Marketing through 1998. Washington, DC: Food and Drug Administration (Center for Drug Evaluation and Research); 1998.
Anderson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
Naylor AM. Endogenous neurotransmitters mediating penile erection. Br J Urol 1998; 81: 424-31.
Rajfer J, Aronson WJ, Bush PA, Dory FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Eng J Med 1992; 326: 90-4.
Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48.
Bohlen JG, Held JP, Sanderson MO, Patterson RP. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med 1984; 144: 1745-8.
Drory Y, Shapira I, Fisman EZ, Pines A. Myocardial ischemia during sexual activity in patients with coronary artery disease. Am J Cardiol 1995; 75: 835-7.
Drory Y, Fisman EZ, Shapira Y, Puines A. Ventricular arrhythmia during sexual activity in patients with coronary artery disease. Chest 1996; 109: 992-4.
Johnston BL, Fletcher GF. Dynamic electrocardiographic recording during sexual activity in recent post-myocardial infarction and revascularization patients. Am Heart J 1979; 98: 736-41.
Jackson G. Sexual intercourse and angina pectoris. Int Rehabil Med 1981; 3: 35-7.
Ueno M. The so-called coition death. Jpn J Leg Med 1963; 17: 330-40.
Muller JE, Mittleman A, Maclure M, Sherwood JB, Tofler GH. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular physical exertion: Determinants of Myocardial Infarction Onset study investigators. JAMA 1996; 275: 1405.
Cheitlin M, Hutter AM, Brindis RG, Ganz P, Kaul S, Russel RO et al. Use of sildenafil in patients with cardiovascular disease: AHA/ACC Expert Consensus Document. J Am Coll Card 1999; 33: 273-82.
Mitka M: Viagra leads as rivals are moving up. JAMA 1998; 280: 119-20.
Webb DJ, Freestone S, Allen MJ, Muirhead GJ: Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999; 83: 21C-28C.
Full text